Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution.

about

Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution.

Item

http://www.wikidata.org/entity/Q47379695

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Leishmanicidal candidate LASSB ...... earance and good distribution.

@en

Leishmanicidal candidate LASSB ...... earance and good distribution.

@nl

type

Item

label

Leishmanicidal candidate LASSB ...... earance and good distribution.

@en

Leishmanicidal candidate LASSB ...... earance and good distribution.

@nl

prefLabel

Leishmanicidal candidate LASSB ...... earance and good distribution.

@en

Leishmanicidal candidate LASSB ...... earance and good distribution.

@nl

P1476

Leishmanicidal candidate LASSB ...... earance and good distribution.

@en

P2093

Barbra Sanches Moraes

http://www.w3.org/2001/XMLSchema#string

Eliezer de Jesus Barreiro

http://www.w3.org/2001/XMLSchema#string

Francine Johansson Azeredo

http://www.w3.org/2001/XMLSchema#string

Jessica Cristina Izoton

http://www.w3.org/2001/XMLSchema#string

Lídia Moreira Lima

http://www.w3.org/2001/XMLSchema#string

Marina Amaral

http://www.w3.org/2001/XMLSchema#string

Rodrigo José Freddo

http://www.w3.org/2001/XMLSchema#string

Sandra Elisa Haas

http://www.w3.org/2001/XMLSchema#string

Teresa Dalla Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure

Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

Mortality and case fatality due to visceral leishmaniasis in Brazil: a nationwide analysis of epidemiology, trends and spatial patterns.

Biopharmaceutics and pharmacokinetics in drug research.

A good practice guide to the administration of substances and removal of blood, including routes and volumes.

Development and validation of a UHPLC-MS/MS bioanalytical method to quantify in plasma the analgesic candidate PT-31 following a preliminary pharmacokinetic study in rats.

Simple HPLC-UV for the quantification of a new leishmanicidal candidate (E)-1-4(trifluoromethyl) benzylidene)-5-(2-4-dichlorozoyl) carbonylhydrazine (LASSBio-1736) in rat plasma for pharmacokinetics assessment.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00498254.2017.1405465

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29160126

http://www.w3.org/2001/XMLSchema#string